Obicetrapib-the Rebirth of CETP Inhibitors?

Curr Atheroscler Rep · 2024 · PMC11393031 · PMID 39150671

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The 2007 ILLUSTRATE trial was a large, 1188 patient intravascular ultrasound (IVUS) study that showed no benefits on progression of atherosclerosis, although intriguingly the secondary endpoint demonstrated marginally significant benefits [ 19 ].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.